Miles W. McHugh is VP at Horizon Therapeutics Public Ltd Co (HZNP). They have made 6 open-market trades across 1 company since 2020, most recently 2022-01-05.
CIK 0001366227
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HZNP | SELL | 2021-12-01 | 2021-12-03 | $106.62 | $16.9M | +7.6% | +8.8% | -1.3% |
| HZNP | SELL | 2020-12-14 | 2020-12-15 | $80.00 | $148K | -9.4% | +1.7% | +19.2% |
| HZNP | SELL | 2020-11-12 | 2020-11-13 | $75.48 | $1.8M | -3.0% | +9.6% | +28.3% |
| HZNP | SELL | 2020-05-08 | 2020-05-12 | $43.88 | $8.3M | +6.7% | -0.7% | +63.2% |
| HZNP | SELL | 2020-05-05 | 2020-05-07 | $39.46 | $477K | +11.0% | +17.7% | +83.5% |
| HZNP | SELL | 2020-02-27 | 2020-02-28 | $34.34 | $34K | -11.4% | -14.8% | +41.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.